|
|
|
By Neil Dhawan and Jason Pontin, Totus Medicines | Before we realize the true potential of advanced artificial intelligence (AI) and machine learning (ML) technologies to treat disease, we need to start by developing technologies that can generate the massive amounts of reliable, high-quality biological data that make up the fundamentals of any AI/ML approach. |
|
|
|
| Harness High-Quality PBPK Modeling To Enhance Clinical Readiness | Article | By Deanna Mudie, Ph.D., Lonza, and John DiBella, Simulations Plus | Advancements in PBPK modeling are enabling drug sponsors to identify poor absorption properties early in development, helping them to mitigate risk in their preclinical and clinical studies. |
|
|
|
|
| Defining A Process For Your Unique mRNA | Infographic | Sartorius | Define a process for your unique mRNA with this interactive guide to pDNA, mRNA, and LNP. Overcome challenges with solutions that can help you develop a next-generation production strategy. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIFE SCIENCE LEADER MAGAZINE |
|
|
|
Have you heard of Life Science Leader? Check it out today for access to candid interviews with top-tier executives on how they do business. |
|
|